Abstract
Dopamine and dobutamine have been widely used to treat shock with variable success in newborns. In this retrospective data analysis, we report on the use of adrenaline in 20 neonates with birth asphyxia and shock that was refractory to dopamine and dobutamine. We concluded that adrenaline is a safe and effective drug that can be used as an add-on therapy to dopamine and/or dobutamine in newborns with shock secondary to birth asphyxia.
References
Phillipos EZ, Barrington KJ, Robertson MA. Dopamine versus epinephrine for ionotropic support in the neonate: A randomized double blinded controlled trial. Pediatr Res 1996; 39: 238A.
Paradisis M, Osborn DA. Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise. Cochrane Database System Rev 2004; 1. CD003958.
Daga SR, Gosavi DV, Verma B. Adrenaline for septic shock in newborns. Indian Pediatr 2000; 37: 799–800.
Moran JL, O’Fathartaigh MS, Peisach AR, Chapman MJ, Leppard P. Epinephrine as an ionotropic agent in septic shock: a dose profile analysis. Crit Care Med 1993; 21: 70–77.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rai, R., Singh, D.K. Intravenous adrenaline for shock in neonates. Indian Pediatr 47, 789–790 (2010). https://doi.org/10.1007/s13312-010-0119-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-010-0119-x